Irida Kastrati

Dimethyl Fumarate Inhibits the Nuclear Factor κB Pathway in Breast Cancer Cells by Covalent Modification of p65 Protein

Irida Kastrati, Marton I. Siklos, Esther L. Calderon-Gierszal et al. · Journal of Biological Chemistry · 2015 · 141 citations · Full text

Life Sciences, Molecular Biology, Oncology +8

Benzothiophene Selective Estrogen Receptor Modulators with Modulated Oxidative Activity and Receptor Affinity

Zhihui Qin, Irida Kastrati, R. Esala P. Chandrasena et al. · Journal of Medicinal Chemistry · 2007 · 138 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +16

Structural and Molecular Mechanisms of Cytokine-Mediated Endocrine Resistance in Human Breast Cancer Cells

Joshua D. Stender, J.C. Nwachukwu, Irida Kastrati et al. · Molecular Cell · 2017 · 119 citations · Full text

Life Sciences, Cell Biology, Oncology +16

Full antagonism of the estrogen receptor without a prototypical ligand side chain

Sathish Srinivasan, J.C. Nwachukwu, Nelson E. Bruno et al. · Nature Chemical Biology · 2016 · 62 citations

Life Sciences, Biochemistry, Pharmacology +14

The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor–Positive Breast Cancers

Irida Kastrati, Stacey E. P. Joosten, Svetlana E. Semina et al. · Molecular Cancer Research · 2020 · 62 citations · Full text

Medicine, Cancer Biology, Oncology +17